These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 22098973)

  • 1. Re: Antimuscarinics and bladder outlet obstruction: from a contraindication to an indication?
    Wein AJ
    J Urol; 2011 Apr; 185(4):1380-1. PubMed ID: 22098973
    [No Abstract]   [Full Text] [Related]  

  • 2. Antimuscarinics and bladder outlet obstruction: From a contraindication to an indication?
    Athanasopoulos A
    Neurourol Urodyn; 2010; 29 Suppl 1():S46-50. PubMed ID: 20127792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of antimuscarinics in the management of men with symptoms of overactive bladder associated with concomitant bladder outlet obstruction: an update.
    Athanasopoulos A; Chapple C; Fowler C; Gratzke C; Kaplan S; Stief C; Tubaro A
    Eur Urol; 2011 Jul; 60(1):94-105. PubMed ID: 21497434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Re: safety and tolerability of tolterodine for the treatment of overactive bladder in men with bladder outlet obstruction.
    Schaefer W
    J Urol; 2006 Nov; 176(5):2311-2; author reply 2312-3. PubMed ID: 17070326
    [No Abstract]   [Full Text] [Related]  

  • 5. Defining the role of overactive bladder treatments in men with lower urinary tract symptoms.
    Lemack GE
    Nat Clin Pract Urol; 2007 Apr; 4(4):174-5. PubMed ID: 17415351
    [No Abstract]   [Full Text] [Related]  

  • 6. A shifted paradigm for the further understanding, evaluation, and treatment of lower urinary tract symptoms in men: focus on the bladder.
    Chapple CR; Roehrborn CG
    Eur Urol; 2006 Apr; 49(4):651-8. PubMed ID: 16530611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of doxazosin with or without tolterodine in men with symptomatic bladder outlet obstruction and an overactive bladder.
    Athanasopoulos AA; Perimenis PS
    BJU Int; 2005 May; 95(7):1117-8. PubMed ID: 15839945
    [No Abstract]   [Full Text] [Related]  

  • 8. When to use antimuscarinics in men who have lower urinary tract symptoms.
    Lee JY; Kim DK; Chancellor MB
    Urol Clin North Am; 2006 Nov; 33(4):531-7, x. PubMed ID: 17011389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary nerve growth factor levels in overactive bladder syndrome and lower urinary tract disorders.
    Liu HT; Chen CY; Kuo HC
    J Formos Med Assoc; 2010 Dec; 109(12):862-78. PubMed ID: 21195884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of oral administration of the novel muscarinic receptor antagonist DA-8010 on overactive bladder in rat with bladder outlet obstruction.
    Choi JB; Jeon SH; Kwon EB; Bae WJ; Cho HJ; Ha US; Hong SH; Lee JY; Kim SW
    BMC Urol; 2020 Apr; 20(1):41. PubMed ID: 32303205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Open to debate. The Motion: antimuscarinics are the mainstay of therapy for overactive bladder.
    Chapple C; Cruz F
    Eur Urol; 2008 Jul; 54(1):226-30. PubMed ID: 18439750
    [No Abstract]   [Full Text] [Related]  

  • 12. Muscarinic receptor antagonists for overactive bladder.
    Abrams P; Andersson KE
    BJU Int; 2007 Nov; 100(5):987-1006. PubMed ID: 17922784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Better management of patients with overactive bladder with antimuscarinics?
    MacDiarmid S
    Int J Clin Pract; 2008 Jan; 62(1):3-4. PubMed ID: 18173809
    [No Abstract]   [Full Text] [Related]  

  • 14. Antimuscarinic therapy in men with bladder outlet obstruction.
    Staskin DR; Kaplan SA; Wein AJ
    Curr Urol Rep; 2006 Nov; 7(6):437-9. PubMed ID: 17052436
    [No Abstract]   [Full Text] [Related]  

  • 15. [Use of antimuscarinics in patients with lower urinary tract symptoms for BPH and overactive bladder].
    Ruiz Cerdá JL
    Actas Urol Esp; 2006 Oct; 30(9):849-55. PubMed ID: 17175924
    [No Abstract]   [Full Text] [Related]  

  • 16. Additional correction of OAB symptoms by two anti-muscarinics for men over 50 years old with residual symptoms of moderate prostatic obstruction after treatment with Tamsulosin.
    Kosilov K; Loparev S; Ivanovskaya M; Kosilova L
    Aging Male; 2015 Mar; 18(1):44-8. PubMed ID: 25136746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimuscarinics for the treatment of neurogenic detrusor overactivity.
    Wyndaele JJ
    Spinal Cord; 2013 Jun; 51(6):431. PubMed ID: 23743497
    [No Abstract]   [Full Text] [Related]  

  • 18. Solifenacin plus tamsulosin combination treatment in men with lower urinary tract symptoms and bladder outlet obstruction: a randomized controlled trial.
    Kaplan SA; He W; Koltun WD; Cummings J; Schneider T; Fakhoury A
    Eur Urol; 2013 Jan; 63(1):158-65. PubMed ID: 22831853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urothelial effects of oral agents for overactive bladder.
    Andersson KE; Fullhase C; Soler R
    Curr Urol Rep; 2008 Nov; 9(6):459-64. PubMed ID: 18947510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimuscarinics and overactive bladder: other mechanism of action.
    Yamaguchi O
    Neurourol Urodyn; 2010; 29(1):112-5. PubMed ID: 19693952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.